# KYMRIAH

NDC: 0078-0846
Generic name: tisagenlecleucel
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: CELLULAR THERAPY
Marketing category: Biologic License Application
Dosage form: INJECTION, SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20170830

FDA application: BLA125646

## Active ingredients

- TISAGENLECLEUCEL: 2000000 1/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0846"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0846
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aad3ba54-dfd3-4cb3-9e2b-c5ef89559189